Laurie Gomer is Director, Health System Partnerships at Syapse, a company backed by social+capital, Safeguard Scientifics, Ascension Ventures, and GE Ventures whose precision medicine data platform integrates genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking.
Previously, she was Director of Business Development at AppMedicine, a health care mobile app and communication platform, which used mobile technology to improve patient access to high-quality, cost-effective medical care outside of the doctor's office. Prior to AppMedicine, Laurie worked in Pipeline and Portfolio Planning at Genentech and Business Development at Navigenics (acquired by Life Technologies/Thermo Fisher), a personal genomics company, which was venture backed by Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, and Procter & Gamble. Before joining Navigenics, Laurie worked as a research manager in the Healthcare & Biomedical Practice at Gerson Lehrman Group, a primary investment research firm for institutional investors, venture capital, and private equity firms.
Laurie began her career as a consultant at The Lucas Group, a boutique management consulting firm, where she was a member of the firm's Growth and Acquisitions Practice and assisted with multiple due diligence engagements for private equity firms and corporations. Laurie earned a BA from Davidson College and an MBA from The Fuqua School of Business at Duke University.